REVIEW
|
doi:10.20944/preprints202108.0372.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
immune checkpoint inhibitors; non-small cell lung carcinoma; PD-1; PD-L1; immune PET; immunotherapy; Radiomics; PET/CT
Online: 18 August 2021 (08:20:43 CEST)